HUTCHMED (China) (HCM) Non-Current Deffered Revenue (2015 - 2025)
HUTCHMED (China)'s (HCM) quarterly Non-Current Deffered Revenue came in at $20.1 million in Q4 2025, down 34.6% on a QoQ basis from $30.8 million in Q2 2025.
HUTCHMED (China) (HCM) Non-Current Deffered Revenue (2015 - 2025) Analysis & Trends
HUTCHMED (China) (HCM) has 10 years of Non-Current Deffered Revenue data on file, last reported at $20.1 million in Q4 2025.
- On a quarterly basis, Non-Current Deffered Revenue changed N/A year-over-year to $20.1 million in Q4 2025; TTM through Dec 2025 was $20.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $20.1 million, changed N/A from the prior year.
- Non-Current Deffered Revenue for Q4 2025 stood at $20.1 million, down from $30.8 million in the prior quarter.
- Over the last five years, Non-Current Deffered Revenue for HCM reached as high as $97.2 million in Q2 2023 and fell as low as $190000.0 in Q4 2022.
- Historically, Non-Current Deffered Revenue has averaged $41.8 million across 4 years, with a median of $30.8 million in 2025.
- Across the five-year window, Non-Current Deffered Revenue plunged 37.61% in 2024 and slumped 49.22% in 2025, its largest moves.
- Year by year, Non-Current Deffered Revenue stood at $190000.0 in 2022, then soared by 51045.26% to $97.2 million in 2023, then tumbled by 37.61% to $60.6 million in 2024, then sank by 66.79% to $20.1 million in 2025.
- Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $20.1 million in Q4 2025, $30.8 million in Q2 2025, and $60.6 million in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | HUTCHMED (China) | 241.90 Mn | 243.61 Mn | - | 20.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 20.13 Mn |
| Jun 30, 2025 | 30.79 Mn |
| Jun 30, 2024 | 60.63 Mn |
| Jun 30, 2023 | 97.18 Mn |
| Dec 31, 2022 | 190,000.00 |
| Dec 31, 2020 | 484,000.00 |
| Dec 31, 2019 | 133,000.00 |
| Dec 31, 2018 | 408,000.00 |
| Dec 31, 2017 | 1.99 Mn |
| Dec 31, 2016 | 131,000.00 |
| Dec 31, 2015 | 2.13 Mn |